眼部保健品市场规模、份额和成长分析（按成分类型、适应症、剂型、分销管道和地区划分）：产业预测（2026-2033 年）

预计到 2024 年，眼保健品市场规模将达到 26.7 亿美元，到 2025 年将达到 28.5 亿美元，到 2033 年将达到 47.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.7%。

眼保健品市场的主要驱动力是视力障碍和近视的日益增多，而萤幕使用时间的增加和远端办公趋势进一步加剧了这个问题。眼科疾病（包括老龄化黄斑部病变、干眼症和白内障）的增加，以及眼科医师的建议，都在推动对这些保健品的需求。全球约有22亿人受到视力障碍的影响，因此，尤其是在失明率显着更高的低收入地区，迫切需要有效的解决方案。已开发国家的消费者在医疗产品（包括眼部保健膳食补充剂）上的支出不断增加，进一步推动了市场成长。此外，电子商务的兴起和创新眼部保健产品的推出，带动了线上销售的激增，满足了数百万人的未满足需求，预示着市场将持续强劲增长。

眼保健品市场驱动因素

老龄化黄斑部病变、白内障和干眼症等各种眼科疾病发生率的不断上升，显着推动了对护眼保健品的需求。随着世界人口老化，这些疾病的盛行率可能会进一步上升，扩大了促进和维护眼部健康的产品的市场。消费者越来越倾向选择能够降低这些疾病相关风险的保健品，随着眼部保健意识的不断提高，护眼保健品市场正处于强劲的成长期。

限制眼保健品市场的因素

由于缺乏科学证据支持眼部保健品的长期疗效和安全性，该市场面临严峻挑战。儘管一些个案报告和初步研究表明其具有潜在益处，但缺乏全面的临床试验和一致的调查方法令人担忧。缺乏严谨的科学检验可能会削弱消费者的信任和接受度，最终阻碍市场成长。潜在买家寻求产品功效的确认，而缺乏广泛且有据可查的研究则构成重大阻碍因素，并可能限制眼部保健品市场的整体发展和成功。

眼保健品市场趋势

受消费者对眼部健康重要性以及预防老龄化相关视力问题的意识不断提高的推动，眼保健品市场正经历显着增长。随着越来越多的人认识到营养支持对维持最佳眼部功能的重要性，他们也越来越多地将眼部保健品纳入日常健康计划。这种积极主动的态度反映了整体健康护理的更广泛趋势，该趋势强调预防保健，并寻求能够促进视力清晰度和整体眼部健康的高品质保健品。因此，对眼部健康的日益关注正在影响着该行业的产品供应和行销策略。

目录

介绍

• 分析目的
• 市场覆盖范围
• 定义

分析方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特五力分析

关键市场考量因素

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场魅力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术分析

全球眼部保健品市场规模及依成分类型分類的复合年增长率（2026-2033 年）

• 叶黄素和玉米黄质
• 抗氧化剂
• Omega-3脂肪酸
• Coenzyme Q10
• 黄酮类化合物
• α-硫辛酸
• 虾青素
• 其他的

全球眼保健品市场规模及依适应症分類的复合年增长率（2026-2033 年）

• 老龄化黄斑部病变（AMD）
• 白内障
• 干眼症
• 发炎
• 其他的

全球眼保健品市场规模及按剂型分類的复合年增长率（2026-2033 年）

• 药片
• 胶囊
• 粉末
• 软胶囊
• 液体
• 其他的

全球眼保健品市场规模及按分销管道分類的复合年增长率（2026-2033 年）

• 医院药房
• 零售药房
• 大卖场和超级市场
• 电子商务

全球眼保健品市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2025 年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市占率（2025 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 年比营收比较（2023-2025）

主要企业简介

• 参天製药（日本）
• 乐敦製药（日本）
• Dompe Farmaceutici（义大利）
• Vianex SA（希腊）
• 雅培实验室（美国）
• 博士伦（美国）
• 爱尔康（瑞士）
• 辉瑞公司（美国）
• 诺华公司（瑞士）
• Thea Pharma（法国）
• Similasan AG（瑞士）
• 杰米森健康中心（加拿大）
• Nature's Way（美国）
• NOW Foods（美国）
• Nature's Bounty（美国）
• GNC控股（美国）
• 康宝莱营养品（美国）
• 安丽（美国）
• 丹麦 Pharma Nord
• Solgar（美国）

结论与建议

Eye Health Supplements Market size was valued at USD 2.67 Billion in 2024 and is poised to grow from USD 2.85 Billion in 2025 to USD 4.79 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The market for eye health supplements is primarily driven by the increasing prevalence of vision impairment and myopia, exacerbated by heightened screen usage and remote work trends. Factors such as rising eye conditions including age-related macular degeneration, dry eye syndrome, and cataracts, alongside endorsements from ophthalmologists, are propelling demand for these supplements. With approximately 2.2 billion individuals globally affected by vision issues, particularly in low-income regions where rates of blindness are significantly higher, the need for effective solutions is critical. Consumers in developed countries exhibit high spending on healthcare products, including dietary supplements for eye health, further fueling market growth. Moreover, the surge in online sales due to e-commerce accessibility and the introduction of innovative eye health products cater to the unmet needs of millions, promising robust market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Eye Health Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Eye Health Supplements Market Segments Analysis

Global Eye Health Supplements Market is segmented by Ingredient Type, Indication, Formulation, Distribution Channel and region. Based on Ingredient Type, the market is segmented into Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin and Others. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation and Others. Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, Liquid and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets and E-Commerce. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Eye Health Supplements Market

The increasing occurrence of various eye-related conditions, including age-related macular degeneration, cataracts, and dry eye syndrome, is significantly fueling the demand for eye health supplements. With a continually aging global population, the likelihood of these disorders becoming more prevalent is rising, thereby expanding the market for products designed to promote and maintain optimal eye health. Consumers are increasingly turning to supplements that can potentially mitigate the risks associated with these conditions, leading to a robust growth trajectory in the eye health supplements sector as awareness of eye care continues to gain prominence.

Restraints in the Eye Health Supplements Market

The Eye Health Supplements market faces a significant challenge due to the insufficient scientific evidence supporting their effectiveness and safety over the long term. Despite some anecdotal reports and initial research suggesting potential benefits, the scarcity of comprehensive clinical studies and consistent research methodologies raises concerns. This gap in rigorous scientific validation may undermine consumer trust and acceptance, ultimately impeding market growth. As potential buyers seek assurance about the efficacy of these products, the absence of widespread, well-documented research can serve as a considerable restraint, limiting the overall development and success of eye health supplements in the market.

Market Trends of the Eye Health Supplements Market

The Eye Health Supplements market is experiencing a notable surge driven by increasing consumer awareness surrounding the significance of eye health and the prevention of age-related vision issues. As more individuals recognize the critical role of nutritional support for optimal eye function, they are integrating eye health supplements into their daily wellness routines. This proactive approach reflects a broader trend towards holistic health management, prompting consumers to prioritize preventive care and seek high-quality supplements that promote vision clarity and overall ocular well-being. Consequently, this heightened focus on eye health is shaping product offerings and marketing strategies within the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Eye Health Supplements Market Size by Ingredient Type & CAGR (2026-2033)

• Market Overview
• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

Global Eye Health Supplements Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

Global Eye Health Supplements Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Global Eye Health Supplements Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Hypermarkets & Supermarkets
• E-Commerce

Global Eye Health Supplements Market Size & CAGR (2026-2033)

• North America (Ingredient Type, Indication, Formulation, Distribution Channel)
  • US
  • Canada
• Europe (Ingredient Type, Indication, Formulation, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Ingredient Type, Indication, Formulation, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Ingredient Type, Indication, Formulation, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Ingredient Type, Indication, Formulation, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Santen Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rohto Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dompe Farmaceutici (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vianex S.A. (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Similasan AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jamieson Wellness (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Way (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Bounty (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNC Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amway (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Nord (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solgar (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations